Activation of a cellular stress response and the transcription factor XBP1 in dendritic cells has now been shown to limit the cells' ability to stimulate antitumour immune responses in a mouse model of ovarian cancer.
Notes
References
Cubillos-Ruiz, J. R. et al. Cell 161, 1527–1538 (2015).
Merad, M., Sathe, P., Helft, J., Miller, J. & Mortha, A. Annu. Rev. Immunol. 31, 563–604 (2013).
Spranger, S., Bao, R. & Gajewski, T. F. Nature http://dx.doi.org/10.1038/nature14404 (2015).
Chaput, N., Conforti, R., Viaud, S., Spatz, A. & Zitvogel, L. Oncogene 27, 5920–5931 (2008).
Chen, X. et al. Nature 508, 103–107 (2014).
Iwakoshi, N. N., Pypaert, M. & Glimcher, L. H. J. Exp. Med. 204, 2267–2275 (2007).
Osorio, F. et al. Nature Immunol. 15, 248–257 (2014).
Martinon, F., Chen, X., Lee, A.-H. & Glimcher, L. H. Nature Immunol. 11, 411–418 (2010).
Herber, D. L. et al. Nature Med. 16, 880–886 (2010).
Norian, L. A. et al. Cancer Res. 69, 3086–3094 (2009).
Mellor, A. L. & Munn, D. H. Nature Rev. Immunol. 4, 762–774 (2004).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Merad, M., Salmon, H. A dendritic-cell brake on antitumour immunity. Nature 523, 294–295 (2015). https://doi.org/10.1038/523294a
Published:
Issue Date:
DOI: https://doi.org/10.1038/523294a
- Springer Nature Limited
This article is cited by
-
Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy
Lipids in Health and Disease (2024)
-
Combination therapy with dendritic cell loaded-exosomes supplemented with PD-1 inhibition at different time points have superior antitumor effect in hepatocellular carcinoma
Cancer Immunology, Immunotherapy (2023)
-
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer
Biomarker Research (2022)
-
Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria
Nature Biomedical Engineering (2022)
-
Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance
Cellular and Molecular Life Sciences (2021)